US Stock MarketDetailed Quotes

Kiora Pharmaceuticals (KPRX)

Watchlist

2.690
+0.250+10.25%

Close May 13 16:00 ET

2.690
0.0000.00%

Post 16:04 ET

11.92MMarket Cap-1.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kiora Pharmaceuticals (KPRX) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Total revenue

16M

Operating revenue

--0

--16M

--0

Cost of revenue

Gross profit

Operating expense

21.78%2.5M

-9.21%9.46M

4.95%2.63M

-6.77%2.52M

-6.86%2.26M

-26.34%2.06M

19.90%10.42M

25.80%2.51M

7.89%2.7M

-2.60%2.42M

Selling and administrative expenses

8.25%1.61M

3.66%5.75M

9.88%1.46M

4.55%1.44M

-11.97%1.35M

14.88%1.49M

18.85%5.54M

50.69%1.33M

-2.46%1.38M

40.16%1.54M

-General and administrative expense

8.25%1.61M

3.66%5.75M

9.88%1.46M

4.55%1.44M

-11.97%1.35M

14.88%1.49M

18.85%5.54M

50.69%1.33M

-2.46%1.38M

40.16%1.54M

Research and development costs

57.40%890.5K

-24.15%3.71M

-0.60%1.17M

-18.64%1.07M

-0.23%904.57K

-62.12%565.76K

21.60%4.9M

6.08%1.18M

21.40%1.32M

-34.87%906.68K

Other operating expenses

----

-931.80%-1.97M

---20K

--0

----

---20K

Operating profit

-21.78%-2.5M

-269.50%-9.46M

-4.95%-2.63M

6.77%-2.52M

6.86%-2.26M

-115.56%-2.06M

164.22%5.58M

-25.80%-2.51M

-7.89%-2.7M

2.60%-2.42M

Net non-operating interest income expense

-49.63%139.34K

-29.02%874.04K

-59.19%170.35K

-18.89%201.82K

-34.16%225.24K

24.02%276.63K

656.13%1.23M

1,113.66%417.41K

398.56%248.84K

658.76%342.1K

Non-operating interest income

-49.63%139.34K

-28.64%894K

-56.64%190.31K

-18.89%201.82K

-34.16%225.24K

24.02%276.63K

620.07%1.25M

864.00%438.86K

398.56%248.84K

658.76%342.1K

Non-operating interest expense

----

-6.93%19.96K

----

92.65%21.45K

----

Other net income (expense)

81.28%-54.55K

-206.48%-3.53M

-6,651.66%-4.71M

276.08%1.7M

-66.31%-231.33K

-1,538.52%-291.45K

70.42%-1.15M

68.38%-69.71K

70.90%-963.94K

17.94%-139.1K

Special income (charges)

97.30%-7.43K

-186.10%-3.37M

-2,710.61%-4.68M

290.38%1.72M

-14.59%-137.77K

-2,356.78%-275.19K

69.97%-1.18M

-7.54%-166.51K

73.55%-904.01K

16.28%-120.23K

-Less：Restructuring and merger&acquisition

-97.30%7.43K

-33.57%-1.25M

-4.43%55.89K

-55.89%-1.72M

14.59%137.77K

2,356.78%275.19K

-147.05%-937.47K

-53.75%58.48K

-172.95%-1.1M

-16.28%120.23K

-Less:Impairment of capital assets

----

--0

----

--104.17K

----

-Write off

----

130.28%4.62M

--4.62M

--0

----

5.44%2.01M

--0

5.44%2.01M

----

-Gain on sale of property,plant,equipment

----

--0

----

86.40%-3.86K

----

Other non- operating income (expenses)

-189.96%-47.13K

-714.70%-160.27K

-127.64%-26.76K

60.44%-23.71K

-396.03%-93.56K

-301.50%-16.25K

-9.60%26.07K

247.44%96.8K

-156.69%-59.93K

27.14%-18.86K

Income before tax

-16.81%-2.42M

-314.10%-12.12M

-232.01%-7.17M

81.94%-616.32K

-1.93%-2.26M

-115.39%-2.07M

145.56%5.66M

0.91%-2.16M

40.77%-3.41M

15.00%-2.22M

Income tax

-162.09%-1.28M

-131.48%-649.97K

-643.13K

-112.06K

123.01K

2,186.35%2.07M

2.07M

Net income

-10.26%-2.42M

-401.42%-10.84M

-54.29%-6.52M

100.79%26.81K

3.11%-2.15M

-116.30%-2.19M

128.73%3.59M

-86.17%-4.22M

40.77%-3.41M

15.00%-2.22M

Net income continuous Operations

-10.26%-2.42M

-401.42%-10.84M

-54.29%-6.52M

100.79%26.81K

3.11%-2.15M

-116.30%-2.19M

128.73%3.59M

-86.17%-4.22M

40.77%-3.41M

15.00%-2.22M

Minority interest income

Net income attributable to the parent company

-10.26%-2.42M

-401.42%-10.84M

-54.29%-6.52M

100.79%26.81K

3.11%-2.15M

-116.30%-2.19M

128.73%3.59M

-86.17%-4.22M

40.77%-3.41M

15.00%-2.22M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-10.26%-2.42M

-401.42%-10.84M

-54.29%-6.52M

100.79%26.81K

3.11%-2.15M

-116.30%-2.19M

127.56%3.59M

-86.17%-4.22M

45.77%-3.41M

15.00%-2.22M

Basic earnings per share

-11.54%-0.58

-379.57%-2.6

-35.65%-1.56

101.23%0.01

-1.89%-0.54

-111.13%-0.52

103.84%0.93

56.60%-1.15

88.90%-0.81

92.59%-0.53

Diluted earnings per share

-11.54%-0.58

-403.45%-2.64

-39.13%-1.6

101.23%0.01

-1.89%-0.54

-115.03%-0.52

103.59%0.87

56.60%-1.15

88.90%-0.81

92.59%-0.53

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Total revenue	0	0	0	0	0	0	16M	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--16M	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	21.78%2.5M	-9.21%9.46M	4.95%2.63M	-6.77%2.52M	-6.86%2.26M	-26.34%2.06M	19.90%10.42M	25.80%2.51M	7.89%2.7M	-2.60%2.42M
Selling and administrative expenses	8.25%1.61M	3.66%5.75M	9.88%1.46M	4.55%1.44M	-11.97%1.35M	14.88%1.49M	18.85%5.54M	50.69%1.33M	-2.46%1.38M	40.16%1.54M
-General and administrative expense	8.25%1.61M	3.66%5.75M	9.88%1.46M	4.55%1.44M	-11.97%1.35M	14.88%1.49M	18.85%5.54M	50.69%1.33M	-2.46%1.38M	40.16%1.54M
Research and development costs	57.40%890.5K	-24.15%3.71M	-0.60%1.17M	-18.64%1.07M	-0.23%904.57K	-62.12%565.76K	21.60%4.9M	6.08%1.18M	21.40%1.32M	-34.87%906.68K
Other operating expenses	----	----	----	----	----	-931.80%-1.97M	---20K	--0	----	---20K
Operating profit	-21.78%-2.5M	-269.50%-9.46M	-4.95%-2.63M	6.77%-2.52M	6.86%-2.26M	-115.56%-2.06M	164.22%5.58M	-25.80%-2.51M	-7.89%-2.7M	2.60%-2.42M
Net non-operating interest income expense	-49.63%139.34K	-29.02%874.04K	-59.19%170.35K	-18.89%201.82K	-34.16%225.24K	24.02%276.63K	656.13%1.23M	1,113.66%417.41K	398.56%248.84K	658.76%342.1K
Non-operating interest income	-49.63%139.34K	-28.64%894K	-56.64%190.31K	-18.89%201.82K	-34.16%225.24K	24.02%276.63K	620.07%1.25M	864.00%438.86K	398.56%248.84K	658.76%342.1K
Non-operating interest expense	----	-6.93%19.96K	----	----	----	----	92.65%21.45K	----	----	----
Other net income (expense)	81.28%-54.55K	-206.48%-3.53M	-6,651.66%-4.71M	276.08%1.7M	-66.31%-231.33K	-1,538.52%-291.45K	70.42%-1.15M	68.38%-69.71K	70.90%-963.94K	17.94%-139.1K
Special income (charges)	97.30%-7.43K	-186.10%-3.37M	-2,710.61%-4.68M	290.38%1.72M	-14.59%-137.77K	-2,356.78%-275.19K	69.97%-1.18M	-7.54%-166.51K	73.55%-904.01K	16.28%-120.23K
-Less：Restructuring and merger&acquisition	-97.30%7.43K	-33.57%-1.25M	-4.43%55.89K	-55.89%-1.72M	14.59%137.77K	2,356.78%275.19K	-147.05%-937.47K	-53.75%58.48K	-172.95%-1.1M	-16.28%120.23K
-Less:Impairment of capital assets	----	--0	----	----	----	----	--104.17K	----	----	----
-Write off	----	130.28%4.62M	--4.62M	--0	----	----	5.44%2.01M	--0	5.44%2.01M	----
-Gain on sale of property,plant,equipment	----	--0	----	----	----	----	86.40%-3.86K	----	----	----
Other non- operating income (expenses)	-189.96%-47.13K	-714.70%-160.27K	-127.64%-26.76K	60.44%-23.71K	-396.03%-93.56K	-301.50%-16.25K	-9.60%26.07K	247.44%96.8K	-156.69%-59.93K	27.14%-18.86K
Income before tax	-16.81%-2.42M	-314.10%-12.12M	-232.01%-7.17M	81.94%-616.32K	-1.93%-2.26M	-115.39%-2.07M	145.56%5.66M	0.91%-2.16M	40.77%-3.41M	15.00%-2.22M
Income tax	0	-162.09%-1.28M	-131.48%-649.97K	-643.13K	-112.06K	123.01K	2,186.35%2.07M	2.07M	0	0
Net income	-10.26%-2.42M	-401.42%-10.84M	-54.29%-6.52M	100.79%26.81K	3.11%-2.15M	-116.30%-2.19M	128.73%3.59M	-86.17%-4.22M	40.77%-3.41M	15.00%-2.22M
Net income continuous Operations	-10.26%-2.42M	-401.42%-10.84M	-54.29%-6.52M	100.79%26.81K	3.11%-2.15M	-116.30%-2.19M	128.73%3.59M	-86.17%-4.22M	40.77%-3.41M	15.00%-2.22M
Minority interest income
Net income attributable to the parent company	-10.26%-2.42M	-401.42%-10.84M	-54.29%-6.52M	100.79%26.81K	3.11%-2.15M	-116.30%-2.19M	128.73%3.59M	-86.17%-4.22M	40.77%-3.41M	15.00%-2.22M
Preferred stock dividends
Other preferred stock dividends							0	0	0
Net income attributable to common stockholders	-10.26%-2.42M	-401.42%-10.84M	-54.29%-6.52M	100.79%26.81K	3.11%-2.15M	-116.30%-2.19M	127.56%3.59M	-86.17%-4.22M	45.77%-3.41M	15.00%-2.22M
Basic earnings per share	-11.54%-0.58	-379.57%-2.6	-35.65%-1.56	101.23%0.01	-1.89%-0.54	-111.13%-0.52	103.84%0.93	56.60%-1.15	88.90%-0.81	92.59%-0.53
Diluted earnings per share	-11.54%-0.58	-403.45%-2.64	-39.13%-1.6	101.23%0.01	-1.89%-0.54	-115.03%-0.52	103.59%0.87	56.60%-1.15	88.90%-0.81	92.59%-0.53
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm